During the work of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) group, we reported on vaccine uptake, safety, effectiveness, and waning in specific age groups in Scotland (e.g., 12-17 years) to enable policymakers to make decisions based on evidence generated nearly in real-time [1]. At first, these imperatives appeared methodologically straightforward. However, we soon realised that the seemingly simplest task in theory – i.e., reporting the vaccine uptake – was in fact challenging in practice. We report several caveats that need to be considered when reporting vaccine uptake for a specific age-group at a national level. We also propose a simple stepwise approach for reporting the methods of calculating vaccine uptake in a specific age-group in the context of tracking a large population.


This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Millington, T., Morrison, K., Jeffrey, K., Sullivan, C., Kurdi, A., Fagbamigbe, A., Swallow, B., Shi, T., Shah, S., Kerr, S., Simpson, C., Ritchie, S., Robertson, C., Sheikh, S. & Rudan, I. 2023, 'Caveats in reporting of national vaccine uptake', Journal of Global Health. https://strathprints.strath.ac.uk/87763/

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 03 May 2024
Was this page helpful?